CALC — Calcimedica Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Calcimedica, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -35.8 | -35.6 | -34.4 | -13.7 | -29.6 |
| Depreciation | |||||
| Non-Cash Items | 5.43 | 10.6 | 8.84 | -7.01 | 8.18 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.63 | 1.83 | -0.267 | -0.495 | 0.154 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -31.5 | -22.9 | -25.7 | -21.1 | -21.2 |
| Capital Expenditures | -0.488 | -0.308 | -0.078 | -0.008 | -0.028 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 11.2 | 27.3 | 8.96 | -4.42 | 9.58 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 10.8 | 27 | 8.88 | -4.42 | 9.55 |
| Financing Cash Flow Items | 0 | -0.139 | 10.3 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.695 | -0.139 | 20.9 | 28 | 15.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -20.1 | 3.94 | 4.05 | 2.4 | 3.58 |